Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank20
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-166.35M
↓ 101% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-82.92M
Historical baseline
PeriodValueYoY Change
TTM$-166.35M+13.5%
2024$-192.36M-127.2%
2023$-84.66M-168.9%
2022$-31.48M-62.4%
2021$-19.38M-485.4%
2020$-3.31M-